Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4647002
Max Phase: Preclinical
Molecular Formula: C50H62N4O13
Molecular Weight: 927.06
Molecule Type: Unknown
Associated Items:
ID: ALA4647002
Max Phase: Preclinical
Molecular Formula: C50H62N4O13
Molecular Weight: 927.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCN1CCN(c2cc(O)c3nc4c5c6c7c(C)c(O)c5c(=O)c(c-4oc3c2)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@](C)(O7)C6=O)CC1
Standard InChI: InChI=1S/C50H62N4O13/c1-11-16-53-17-19-54(20-18-53)31-22-32(56)38-34(23-31)66-47-39(51-38)35-36-43(59)29(7)46-37(35)48(61)50(9,67-46)64-21-15-33(63-10)26(4)45(65-30(8)55)28(6)42(58)27(5)41(57)24(2)13-12-14-25(3)49(62)52-40(47)44(36)60/h12-15,21-24,26-28,33,41-42,45,56-59H,11,16-20H2,1-10H3,(H,52,62)/b13-12+,21-15+,25-14-/t24-,26+,27+,28+,33-,41-,42+,45+,50-/m0/s1
Standard InChI Key: KDFFQLYROXGQFM-VDPAUJFTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 927.06 | Molecular Weight (Monoisotopic): 926.4313 | AlogP: 6.19 | #Rotatable Bonds: 5 |
Polar Surface Area: 230.66 | Molecular Species: ACID | HBA: 16 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.52 | CX Basic pKa: 8.33 | CX LogP: 4.11 | CX LogD: 2.51 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.09 | Np Likeness Score: 1.41 |
1. Bera S, Mondal D.. (2019) Insights of synthetic analogues of anti-leprosy agents., 27 (13): [PMID:31103404] [10.1016/j.bmc.2019.04.032] |
Source(1):